Mirae Asset Global Investments Co. Ltd. lessened its holdings in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 4.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 72,865 shares of the company’s stock after selling 3,178 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Avantor were worth $1,672,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in AVTR. Fifth Third Bancorp boosted its stake in Avantor by 125.3% during the 4th quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after purchasing an additional 694 shares during the last quarter. Quarry LP boosted its stake in Avantor by 815.3% during the 1st quarter. Quarry LP now owns 1,437 shares of the company’s stock worth $30,000 after purchasing an additional 1,280 shares during the last quarter. Park Place Capital Corp boosted its stake in Avantor by 18.2% during the 3rd quarter. Park Place Capital Corp now owns 3,039 shares of the company’s stock worth $64,000 after purchasing an additional 467 shares during the last quarter. UniSuper Management Pty Ltd acquired a new position in shares of Avantor during the 2nd quarter valued at about $99,000. Finally, Signaturefd LLC boosted its position in shares of Avantor by 41.7% during the 3rd quarter. Signaturefd LLC now owns 5,979 shares of the company’s stock valued at $126,000 after acquiring an additional 1,759 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.
Insiders Place Their Bets
In other Avantor news, EVP James Bramwell sold 6,203 shares of the business’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total transaction of $151,911.47. Following the sale, the executive vice president now directly owns 101,143 shares in the company, valued at $2,476,992.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.50% of the company’s stock.
Analyst Ratings Changes
Read Our Latest Report on Avantor
Avantor Stock Down 0.8 %
Shares of NYSE:AVTR opened at $24.10 on Friday. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.61 and a quick ratio of 1.05. The firm has a market capitalization of $16.35 billion, a PE ratio of 50.21, a price-to-earnings-growth ratio of 2.47 and a beta of 1.37. The firm’s 50-day moving average is $24.93 and its two-hundred day moving average is $22.47. Avantor, Inc. has a 1 year low of $16.63 and a 1 year high of $26.16.
Avantor (NYSE:AVTR – Get Free Report) last issued its quarterly earnings results on Wednesday, February 14th. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.03. The company had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.70 billion. Avantor had a net margin of 4.61% and a return on equity of 14.11%. The business’s revenue for the quarter was down 4.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.32 earnings per share. Analysts predict that Avantor, Inc. will post 1.01 EPS for the current year.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Further Reading
- Five stocks we like better than Avantor
- Quiet Period Expirations Explained
- MarketBeat Week in Review – 4/15 – 4/19
- The 3 Best Blue-Chip Stocks to Buy Now
- Comprehensive Analysis of PayPal Stock
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Intuitive Surgical Stock Can Trend Much Higher This Year
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.